Table 1.
Variable | With legal involvement (n = 278) | % of total sample | Without legal involvement (n = 331) | % of total sample | Unadjusted p value | Adjusted p valuea |
---|---|---|---|---|---|---|
Age, mean ± SD, yr | 41.0 ± 11.7 | 44.5 ± 12.1 | < .001 | .001 | ||
Male | 180 | 65% | 200 | 60% | .277 | .776 |
Ethnicity | .836 | .999 | ||||
Caucasian | 149 | 54% | 185 | 56% | ||
African-American | 95 | 34% | 109 | 33% | ||
Other | 34 | 12% | 37 | 11% | ||
Uninsured | 57 | 21% | 48 | 15% | .051 | .238 |
PANSS total score, mean ± SD | 86.4 ± 18.3 | 86.9 ± 21.2 | .770 | .772 | ||
SF-36 Mental composite scoreb ± SD | -1.3 ± 1.3 | -0.9 ± 1.3 | < .001 | .001 | ||
SF-36 Physical composite scoreb ± SD | -0.5 ± 1.1 | -0.4 ± 1.0 | .218 | .037 | ||
Not hospitalized in the previous year | 172 | 64% | 245 | 75% | .003 | .034 |
ER use in the previous 3 months | 87 | 32% | 76 | 24% | .021 | .056 |
Lifetime substance abuse diagnosis | 145 | 52% | 117 | 35% | < .001 | < .001 |
Drink alcohol to intoxication | 29 | 11% | 19 | 6% | .049 | .088 |
Cannabis use | 60 | 22% | 19 | 6% | < .001 | < .001 |
Cocaine use | 23 | 8% | 6 | 2% | < .001 | .001 |
MPR ≥ 80% | 92 | 36% | 146 | 50% | .001 | .015 |
MPR, mean ± SD | 0.5 ± 0.4 | 0.6 ± 0.4 | < .001 | .001 | ||
Discontinued study | 84 | 30% | 72 | 22% | .020 | .053 |
Mean days to study discontinuation, mean ± SD | 312.6 ± 93.9 | 325.3 ± 84.2 | .082 | .136 |
Abbreviations: ER, emergency room; MPR, medication possession ratio; PANSS, positive and negative syndrome scale; SD, standard deviation; SF-36, Medical Outcome--Short Form 36. Possible PANSS scores range from 30 to 210, with higher scores indicating greater pathology. SF-36 standardized scores are relative to the general population, where smaller negative scores indicate better health.
aAdjusted p value for age, gender, and ethnicity.
bWeighted averages of the Z-scores of the 8 Medical Outcome--Short Form 36 domain scores as related to general population norms.